Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Advances in Experimental Medicine and Biology
|
March 18, 2000
Brain tryptophan/serotonin perturbations in metabolic encephalopathy and the hazards involved in the use of psychoactive drugs
F Bengtsson
Advances in Experimental Medicine and Biology
|
January 1, 1996
Neuropsychiatric implications of brain tryptophan perturbations appearing in hepatic encephalopathy
F Bengtsson, P Bergqvist
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 1, 1989
Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis
B K Siesjö, F Bengtsson
Therapeutic Drug Monitoring
|
October 16, 1999
Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report
E Skogh, F Bengtsson, C Nordin
Therapeutic Drug Monitoring
|
August 15, 2000
Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting
J Lundmark, M Reis, F Bengtsson
Therapeutic Drug Monitoring
|
April 11, 2001
Serum concentrations of fluoxetine in the clinical treatment setting
J Lundmark, M Reis, F Bengtsson
The European Journal of Neuroscience
|
December 8, 2004
Feedback control of Purkinje cell activity by the cerebello-olivary pathway
F Bengtsson, P Svensson, G Hesslow
Experimental Brain Research
|
September 1, 2005
Cerebellar inhibition of inferior olivary transmission in the decerebrate ferret
P Svensson, F Bengtsson, G Hesslow
International Clinical Psychopharmacology
|
September 19, 2000
Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality
L Ekselius, F Bengtsson, L von Knorring
Advances in Experimental Medicine and Biology
|
January 1, 1997
Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice
F Bengtsson, P B Bergqvist, G Apelqvist
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Advances in Experimental Medicine and Biology
|
March 18, 2000
Brain tryptophan/serotonin perturbations in metabolic encephalopathy and the hazards involved in the use of psychoactive drugs
F Bengtsson
Advances in Experimental Medicine and Biology
|
January 1, 1996
Neuropsychiatric implications of brain tryptophan perturbations appearing in hepatic encephalopathy
F Bengtsson, P Bergqvist
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 1, 1989
Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis
B K Siesjö, F Bengtsson
Therapeutic Drug Monitoring
|
October 16, 1999
Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report
E Skogh, F Bengtsson, C Nordin
Therapeutic Drug Monitoring
|
August 15, 2000
Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting
J Lundmark, M Reis, F Bengtsson
Therapeutic Drug Monitoring
|
April 11, 2001
Serum concentrations of fluoxetine in the clinical treatment setting
J Lundmark, M Reis, F Bengtsson
The European Journal of Neuroscience
|
December 8, 2004
Feedback control of Purkinje cell activity by the cerebello-olivary pathway
F Bengtsson, P Svensson, G Hesslow
Experimental Brain Research
|
September 1, 2005
Cerebellar inhibition of inferior olivary transmission in the decerebrate ferret
P Svensson, F Bengtsson, G Hesslow
International Clinical Psychopharmacology
|
September 19, 2000
Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality
L Ekselius, F Bengtsson, L von Knorring
Advances in Experimental Medicine and Biology
|
January 1, 1997
Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice
F Bengtsson, P B Bergqvist, G Apelqvist
Page
of 9